肝硬化患者中再生结节、异型增生结节与小肝癌的鉴别:基于对比增强超声的多变量模型分析
本研究基于2011年1月至2014年11月单中心149例患者162个经病理证实的局灶性肝病灶,构建结合定性CEUS特征和对比剂到达时间比(CATR)的多变量模型,用于鉴别肝硬化肝病灶(再生结节<异型增生结节<小肝癌)。CEUS+CATR模型乐观校正后Harrell一致性指数CH为0.92(95%CI 0.89-0.95),优于CATR模型(ΔCH 0.09,95%CI 0.04-0.13,p<.001)和CEUS模型(ΔCH 0.03,95%CI 0.01-0.05,p=.02)。
要点
- CATR每降低0.1单位,结节排名更高的比值比为0.32(95%CI 0.20-0.50,p<.001)。
- 动脉期低增强和等增强相比高增强与更高结节排名的关联呈反向。
- CEUS+CATR模型CH 0.92(95%CI 0.89-0.95),鉴别能力优于CATR模型和CEUS模型。
核心结论
- 结合定性CEUS特征与CATR的多变量回归模型对肝硬化患者再生结节、异型增生结节和小肝癌具有最大的鉴别能力,可能有助于肝硬化肝病灶进展的主动监测。
研究设计与样本
- 单中心研究,纳入2011年1月至2014年11月本院149例患者(113男、36女,平均年龄53.4±12.7岁)的162个局灶性肝病灶,均有活检或切除病理及术前CEUS。
- 采用定性的CEUS特征和/或对比剂到达时间比(CATR)构建单变量和多变量回归模型。
- 以乐观校正的Harrell广义一致性指数(CH)量化各CEUS特征和模型的鉴别能力。
关键影像表现/征象
- 动脉期低增强和等增强相比高增强与更高结节排名的关联呈反向。
- 晚期等增强与更高结节排名的比值比降低相关。
诊断标准与关键数值
- CATR每降低0.1单位,结节排名更高的比值比为0.32(95%CI 0.20-0.50,p<.001),对应68%的比值增加。
- CEUS+CATR模型CH 0.92(95%CI 0.89-0.95),CATR模型ΔCH 0.09(95%CI 0.04-0.13,p<.001),CEUS模型ΔCH 0.03(95%CI 0.01-0.05,p=.02)。
临床应用与阅片要点
- 作者认为,结合定性CEUS特征与CATR的多变量回归模型对肝硬化患者再生结节、异型增生结节和小肝癌的鉴别提供了最大的鉴别能力,并可能允许对肝硬化肝病灶进展进行主动监测。
局限性
- 原文结论称结果为初步证据(preliminary evidence)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To develop a contrast-enhanced ultrasound (CEUS)-based model for differentiating cirrhotic liver lesions and for active surveillance of hepatocellular carcinoma (HCC).
METHODS: Patients with focal liver lesions (FLLs) with biopsy/resection-proven pathology and pre-procedure CEUS were enrolled from our institution between January 2011 and November 2014. Univariable and multivariable regression models were constructed using qualitative CEUS features and/or contrast arrival time ratio (CATR). The optimism-adjusted Harrell's generalized concordance index (CH) was used to quantify the discriminatory ability of each CEUS feature and model.
RESULTS: A total of 149 patients (113 men and 36 women) with 162 FLLs were enrolled with mean age 53.4 ± 12.7 years. A 0.1-unit reduction in CATR was associated with a 68% increase in the odds of having a higher nodule ranking (RN < DN < small HCC) (OR, 0.32; 95% CI, 0.20-0.50, p < .001). Arterial phase hypoenhancement and isoenhancement were inversely associated with a higher nodule ranking compared to hyperenhancement. Late-phase isoenhancement was associated with lower odds of a higher nodule ranking. The CEUS + CATR model (CH 0.92, 0.89-0.95) provided greater discriminatory ability when compared to the CATR model (ΔCH 0.09, 0.04-0.13, p < .001) and the CEUS model (ΔCH 0.03, 0.01-0.05, p = .02).
CONCLUSIONS: Our results provide preliminary evidence that multivariable regression model constructed using both qualitative CEUS features and CATR provides the greatest discriminatory ability to differentiate RN, DN, and small HCC in patients with cirrhosis, and might allow for active surveillance of the progression of cirrhotic liver lesions.
KEY POINTS: • Proportional odds logistic regression models based on qualitative CEUS features and/or CATR can be used for differentiating cirrhotic liver lesions and for active surveillance of HCC. • The reduction of CATR (RN < DN < small HCC) was strongly associated with high-risk cirrhotic liver nodules. • Inclusion of CATR in the CEUS prediction model significantly improved its performance for cirrhotic liver lesions risk-stratification.
引用
- Duan Y, Xie X, Li Q, et al. Differentiation of regenerative nodule, dysplastic nodule, and small hepatocellular carcinoma in cirrhotic patients: a contrast-enhanced ultrasound-based multivariable model analysis. Eur Radiol. 2020. PMID: 32307563. doi:10.1007/s00330-020-06834-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。